Vitalibis Inc (VCBD)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Vitalibis Total Liabilities (Quarterly): 0.1049M for Sept. 30, 2017
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | 1.903M |
| June 30, 2020 | 2.138M |
| March 31, 2020 | 2.246M |
| December 31, 2019 | 1.710M |
| September 30, 2019 | 1.724M |
| June 30, 2019 | 0.7842M |
| March 31, 2019 | 0.2358M |
| December 31, 2018 | 0.1804M |
| September 30, 2018 | 0.0462M |
| June 30, 2018 | 0.0765M |
| March 31, 2018 | 0.0215M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.0062M |
| September 30, 2017 | 0.1049M |
| June 30, 2017 | 0.0741M |
| March 31, 2017 | 0.0252M |
| December 31, 2016 | 0.0011M |
| September 30, 2016 | 0.107M |
| June 30, 2016 | 0.097M |
| March 31, 2016 | 0.083M |
| December 31, 2015 | 0.08M |
| September 30, 2015 | 0.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7842M
Minimum
Jun 2019
2.246M
Maximum
Mar 2020
1.751M
Average
1.813M
Median
Total Liabilities (Quarterly) Benchmarks
| Humanigen Inc | 54.84M |
| Item 9 Labs Corp | 59.37M |
| Cantabio Pharmaceuticals Inc | 2.215M |
| Affymax Inc | -- |
| Statera BioPharma Inc | 22.92M |
Total Liabilities (Quarterly) Related Metrics
| Shareholders Equity (Quarterly) | -0.1049M |